Morningstar

Spark Biomedical and Velentium Medical Strengthen Partnership Through Launch of New Femtech Wellness Product

Spark Biomedical and Velentium Medical, longtime partners in neuromodulation device development, today announced their partnership in the launch of OhmBody™, a division of Spark Biomedical pioneering ...
Business Insider

Spark Biomedical Publishes Peer-Reviewed Trial Showing Wearable Device Reduces Heavy Menstrual Bleeding

Dallas, TX, Oct. 15, 2025 (GLOBE NEWSWIRE) -- Spark Biomedical, the parent company of OhmBody, a women’s wellness division focused on wearable neurostimulation technology, has published the first peer ...

UT Southwestern and UTMB Awarded $500,000 TRC4 Grant to Study Non-Invasive Neurostimulation for Chronic Subdural Hematomas

Chronic subdural hematomas account for over 90,000 hospitalizations annually and are projected to become the most common neurosurgical condition by 2030. Current interventions--including surgery and ...
KTLA

Spark Biomedical Launches Telehealth Services for Sparrow Ascent, Improving Patient Access to Opioid Withdrawal Treatment

DALLAS, TX, Aug. 08, 2023 (GLOBE NEWSWIRE) -- Spark Biomedical Launches Telehealth Services for Sparrow Ascent, Improving Patient Access to Opioid Withdrawal Treatment August 8, 2023, Dallas, TX ...
Morningstar

Spark Biomedical Completes Enrollment in a Neurostimulation Pivotal Trial for Opioid Use Disorder

Spark Biomedical’s Co-founder & Chief Science Officer, Dr. Navid Khodaparast, Ph.D., shared, “Completing enrollment marks a critical milestone in advancing transcutaneous auricular neurostimulation as ...
MediaPost

Spark Biomedical Kindles Biz By Helping Fight Opioid Addiction

Over the past couple of years, about a thousand people have used a wearable ear device called Sparrow Ascent as a means to withdraw from opioid addiction. The device sends mild electrical ...
NBC4 Columbus

Spark Biomedical Sets Sights on Global Expansion with New ISO 13485 and MDSAP Certifications

Dallas, TX, Nov. 18, 2024 (GLOBE NEWSWIRE) -- Spark Biomedical, a leading developer of wearable neurostimulation devices, proudly announces the recent achievement of ISO 13485:2016 and MDSAP Quality ...
MarketWatch

Spark Biomedical Partners With Air Force To Launch Trial Testing Innovative Solution to Motion Sickness and Spatial Disorientation

This trial will test the feasibility of wearable neurostimulation to help reduce fatal disorientation-related errors in the military. Dallas, TX, Feb. 20, 2025 (GLOBE NEWSWIRE) -- Spark Biomedical, a ...